Novo Holdings's Medical Portfolio

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

Route 92 Medical is a medical device company developing a catheter to treat stroke.

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

Bactolife is a biotechnology company that develops biological solutions to support gut health.

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.

MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.

Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.

Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.